The acceptance of applications for the international competition within the framework of the BRICS is open. International Consortium Partners — China, India, South Africa, Brazil.

The competition is focused on supporting enterprises performing promising developments in the following areas:

1. Development of new technologies / tools for the diagnosis of COVID-19.

2. Development of vaccines against COVID-19.

3. Genomic sequencing of SARS-CoV-2 and studies on the epidemiology and mathematical modeling of the COVID-19 pandemic.

4. Research in the field of artificial intelligence, information and communication technologies and high-performance computing, aimed at the development of vaccines, methods of therapy, clinical trials, as well as infrastructure and health systems.

5. Epidemiological studies and clinical trials to assess the imposition of SARS-CoV-2 and related diseases, especially tuberculosis.

The project should be implemented by organizations from three countries (a participant from Russia + participants from two countries — members of the BRICS).

Grants are provided to small innovative enterprises in the amount of not more than 15 million rubles, subject to co-financing from own and (or) borrowed funds of third parties in the amount of not less than 30% of the grant amount. The term for research and development (R&D) is 18 or 24 months.

You can submit an application through the AS «Fund-M» system at the address: online.fasie.ru.

Applications are accepted until 10:00 on September 2, 2020. Note that, in addition to the application to the fund, a general application must be submitted on the brics-sti.org website before 08/18/2020, as well as applications from partners to the appropriate national funding organizations.

Details on the site Innovation Promotion Fund.

You can get advice on emerging issues at the Innovation Agency of the Rostov Region by phone +7 (961) 293-46-95, e-mail rostov@fasie.ru, or by filling out the form on the website of the fund’s representative office — here fasie61.ru.